Mesa Long Term Debt vs Total Assets Analysis
MLAB Stock | USD 109.09 8.23 8.16% |
Mesa Laboratories financial indicator trend analysis is infinitely more than just investigating Mesa Laboratories recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mesa Laboratories is a good investment. Please check the relationship between Mesa Laboratories Long Term Debt and its Total Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.
Long Term Debt vs Total Assets
Long Term Debt vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mesa Laboratories Long Term Debt account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Mesa Laboratories' Long Term Debt and Total Assets is 0.92. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Total Assets in the same time period over historical financial statements of Mesa Laboratories, assuming nothing else is changed. The correlation between historical values of Mesa Laboratories' Long Term Debt and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Mesa Laboratories are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Long Term Debt i.e., Mesa Laboratories' Long Term Debt and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.92 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Long Term Debt
Long-term debt is a debt that Mesa Laboratories has held for over one year. Long-term debt appears on Mesa Laboratories balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Mesa Laboratories balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Total Assets
Total assets refers to the total amount of Mesa Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Mesa Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Mesa Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mesa Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.At present, Mesa Laboratories' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 564.5 M, whereas Tax Provision is projected to grow to (20.3 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 109.1M | 133.7M | 133.3M | 139.9M | Total Revenue | 184.3M | 219.1M | 216.2M | 227.0M |
Mesa Laboratories fundamental ratios Correlations
Click cells to compare fundamentals
Mesa Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mesa Laboratories fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 420.2M | 600.2M | 707.4M | 661.8M | 446.8M | 469.1M | |
Other Current Liab | 14.7M | 9.9M | 14.8M | 20.0M | 18.2M | 19.1M | |
Total Current Liabilities | 26.0M | 32.6M | 48.1M | 43.4M | 44.3M | 46.5M | |
Total Stockholder Equity | 220.0M | 406.2M | 393.8M | 393.5M | 145.4M | 74.1M | |
Property Plant And Equipment Net | 22.1M | 22.0M | 28.6M | 28.1M | 41.4M | 43.5M | |
Net Debt | 60.0M | (117.2M) | 171.8M | 137.4M | 203.1M | 213.2M | |
Retained Earnings | 71.9M | 72.5M | 76.7M | 74.2M | (183.5M) | (174.3M) | |
Cash | 81.4M | 263.9M | 49.3M | 32.9M | 28.2M | 17.3M | |
Non Current Assets Total | 297.4M | 297.1M | 583.1M | 542.9M | 337.4M | 354.3M | |
Non Currrent Assets Other | 275.3M | 275.1M | 11.8M | 209.0M | 867K | 823.7K | |
Other Assets | 11.5M | 275.1M | 554.4M | 2.8M | 1.0 | 0.95 | |
Cash And Short Term Investments | 81.4M | 263.9M | 49.3M | 32.9M | 28.2M | 17.5M | |
Net Receivables | 21.1M | 23.8M | 41.2M | 42.6M | 39.1M | 41.0M | |
Common Stock Shares Outstanding | 4.4M | 5.1M | 5.3M | 5.4M | 5.4M | 4.3M | |
Liabilities And Stockholders Equity | 420.2M | 600.2M | 707.4M | 661.8M | 446.8M | 469.1M | |
Inventory | 14.2M | 11.2M | 24.6M | 34.6M | 32.7M | 34.3M | |
Other Stockholder Equity | 60K | 16.1M | 323.1M | (12.8M) | (1.0) | (0.95) | |
Total Liab | 200.2M | 193.9M | 313.6M | 268.4M | 301.4M | 316.5M | |
Property Plant And Equipment Gross | 22.1M | 22.0M | 46.3M | 47.9M | 54.3M | 57.0M | |
Total Current Assets | 122.8M | 303.0M | 124.3M | 119.0M | 109.4M | 114.8M | |
Accumulated Other Comprehensive Income | (9.9M) | 16.1M | 3.7M | (12.8M) | (14.8M) | (14.0M) | |
Non Current Liabilities Total | 174.2M | 162.7M | 265.5M | 225.0M | 257.1M | 269.9M | |
Other Current Assets | 41.4M | 4.9M | 9.1M | 86.1M | 9.4M | 10.2M | |
Short Long Term Debt Total | 141.4M | 146.7M | 221.1M | 186.1M | 231.3M | 242.9M | |
Accounts Payable | 3.4M | 4.5M | 7.9M | 6.1M | 6.0M | 6.3M | |
Short Term Debt | 1.1M | 14.8M | 6.9M | 2.9M | 3.0M | 4.5M | |
Intangible Assets | 119.9M | 111.7M | 250.1M | 18.2M | 113.8M | 119.4M | |
Common Stock Total Equity | 39.8M | 158.0M | 317.7M | 332.1M | 381.9M | 401.0M | |
Common Stock | 158.0M | 317.7M | 313.5M | 332.1M | 343.6M | 360.8M | |
Property Plant Equipment | 22.1M | 22.0M | 28.6M | 28.1M | 32.4M | 34.0M | |
Good Will | 141.5M | 160.8M | 291.2M | 286.4M | 180.1M | 189.1M | |
Current Deferred Revenue | 6.8M | 8.8M | 14.6M | 14.4M | 15.5M | 16.3M | |
Long Term Debt | 140.3M | 145.7M | 218.4M | 183.3M | 221.7M | 232.8M | |
Net Tangible Assets | (41.4M) | 294.5M | 393.8M | 107.0M | 123.1M | 101.8M | |
Retained Earnings Total Equity | 73.3M | 71.9M | 72.5M | 74.2M | 85.3M | 68.3M | |
Other Liab | 32.6M | 193.9M | 39.7M | 36.0M | 41.4M | 32.9M | |
Long Term Debt Total | 20.6M | 140.3M | 145.7M | 183.3M | 210.8M | 221.3M | |
Non Current Liabilities Other | 1.4M | 715K | 7.9M | 7.7M | 15.6M | 16.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.875 | Dividend Share 0.64 | Earnings Share (45.62) | Revenue Per Share 42.3 | Quarterly Revenue Growth 0.088 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.